The Division of Movement Disorders provides comprehensive evaluation and treatment for patients with a broad range of movement disorders, including Parkinson’s disease, tremor, and dystonia. Our team of physicians, nurses, and researchers is dedicated to advancing the understanding and treatment of Parkinson’s disease and related disorders. The Division of Movement Disorders is a collaboration with Massachusetts General Hospital and works with the Parkinson Study Group nationally.
Research projects include efforts to identify a disease-modifying therapy for Parkinson’s disease; efforts to identify biomarkers to diagnose, track, and monitor treatment response, and genetic studies; and DNA and tissue banking for Parkinson’s and related disorders.
Led by Lewis R. Sudarsky, MD, the Division provides comprehensive evaluation and treatment for patients with Parkinson’s disease and other movement disorders, including approved and investigational therapies. We also provide botulinum toxin injections for focal dystonia and hemifacial spasm. We offer functional neurosurgery, including deep brain stimulation (DBS) for select patients with Parkinson’s disease, essential tremor, and dystonia and selective denervation techniques for cervical dystonia or torticollis.